BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9240065)

  • 1. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in infant immunization against hepatitis B: did intervention work?
    Takayama JI; Iser JP; Gandelman A
    Prev Med; 1999 Feb; 28(2):160-6. PubMed ID: 10048107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers].
    van der Ploeg CP; Kateman H; Vermeer-de Bondt PE; Verkerk PH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1820-4. PubMed ID: 15495511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing for the next public debate: universal vaccination against hepatitis B.
    Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
    Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why should Australia adopt universal infant hepatitis B vaccination?
    Thompson SC; Oman K
    Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
    [No Abstract]   [Full Text] [Related]  

  • 14. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation.
    Sloan D; Ramsay M; Prasad L; Gelb D; Teo CG
    Vaccine; 2005 Dec; 23(48-49):5500-8. PubMed ID: 16112253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and control of hepatitis B in China.
    Sun Z; Ming L; Zhu X; Lu J
    J Med Virol; 2002 Jul; 67(3):447-50. PubMed ID: 12116043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjustment of the hepatitis-B vaccination scheme for newborns born to hepatitis-B virus carriers as of 1 January 2006].
    Geelen SP
    Ned Tijdschr Geneeskd; 2006 Feb; 150(8):415-8. PubMed ID: 16538839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infant HBV immunisation.
    Commun Dis Rep CDR Wkly; 1992 Jul; 2(30):133. PubMed ID: 1285176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.